# CAR-T cell therapy: Materials

Source page: https://www.materialinsights.org/technologies/car_t_cell_therapy/tech-materials/

#### Critical materials

The materials whose supply could hold it back

- No commodity material limits CAR-T: the bottleneck is making each patient's cells, which takes about 3 to 5 weeks ^[1].
- Manufacturing is concentrated in a few specialised plants, such as Novartis's site in Morris Plains, New Jersey, for Kymriah ^[3].

as of 2026-11-11

#### Sources

1. [CAR T Cells: Engineering Patients' Immune Cells to Treat Their Cancers](https://www.cancer.gov/about-cancer/treatment/research/car-t-cells) National Cancer Institute (NIH), 2025
2. [FDA Approves Novartis' CAR-T Drug, First Gene Therapy Approval in US](https://www.pharmtech.com/view/fda-approves-novartis-car-t-drug-first-gene-therapy-approval-us-0) Pharmaceutical Technology, 2017

## Other sections

- [Summary](https://www.materialinsights.org/technologies/car_t_cell_therapy/index.md)
- [Overview](https://www.materialinsights.org/technologies/car_t_cell_therapy/tech-overview/index.md)
- [Science](https://www.materialinsights.org/technologies/car_t_cell_therapy/tech-science/index.md)
- [Evolution](https://www.materialinsights.org/technologies/car_t_cell_therapy/tech-evolution/index.md)
- [Energy footprint](https://www.materialinsights.org/technologies/car_t_cell_therapy/tech-energy-footprint/index.md)
- [Industries](https://www.materialinsights.org/technologies/car_t_cell_therapy/tech-industries/index.md)
